{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:19:11Z","timestamp":1793697551604,"version":"4.5.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T00:00:00Z","timestamp":1319760000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00198-011-1806-8","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T20:03:40Z","timestamp":1319745820000},"page":"1789-1797","source":"Crossref","is-referenced-by-count":54,"title":["Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study"],"prefix":"10.1007","volume":"23","author":[{"given":"M.-S. M.","family":"Ardawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Al-Sibiany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. M.","family":"Bakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Rouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. H.","family":"Qari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,28]]},"reference":[{"key":"1806_CR1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10735-007-9096-3","volume":"38","author":"G Silvestrini","year":"2007","unstructured":"Silvestrini G, Ballanti P, Leopizzi M, Sebastiani M, Berni S, DiVitro M, Bonucci E (2007) Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone. J Molecu Histol 38:261","journal-title":"J Molecu Histol"},{"key":"1806_CR2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1138\/20090388","volume":"6","author":"M Kneissel","year":"2009","unstructured":"Kneissel M (2009) The promise of sclerostin inhibition for the treatment of osteoporosis. IBM S BoneKEy 6:259\u2013264","journal-title":"IBM S BoneKEy"},{"key":"1806_CR3","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","volume":"280","author":"X Li","year":"2005","unstructured":"Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, Wu D (2005) Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling. J Biol Chem 280:19883\u201319887","journal-title":"J Biol Chem"},{"key":"1806_CR4","first-page":"1738","volume":"21","author":"DL Ellies","year":"2006","unstructured":"Ellies DL, Viviano B, McCarthy J, Rey JP, Itasaki N, Saunders S, Krumlauf R (2006) Bone density ligand, sclerostin, directly interacts with LRP5 but not LRP5\/6 and antagonizes canonical Wnt signaling. J Biol Chem 21:1738\u20131749","journal-title":"J Biol Chem"},{"key":"1806_CR5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","volume":"68","author":"ME Brunkow","year":"2001","unstructured":"Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Zhao L, Sabo PJ, Fu Y, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan J (2001) Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68:577\u2013589","journal-title":"Am J Hum Genet"},{"key":"1806_CR6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.10401","volume":"110","author":"K Staehling-Hampton","year":"2002","unstructured":"Staehling-Hampton K, Proll S, Paeper BW, Zhao L, Charmely P, Brown A, Gardner JC, Galas D, Schatzman RC, Beighton P, Papapoulos S, Hamersma H, Brunkow ME (2002) A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12\u2013q21 is associated with van Buchem disease in the Dutch population. Am J Med Genet 110:144\u2013152","journal-title":"Am J Med Genet"},{"key":"1806_CR7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","volume":"39","author":"W Balemans","year":"2002","unstructured":"Balemans W, Patel N, Ebeling M, van Hul E, Wuyts W, Lacza C, Dioszegi M, Dikkers FG, Hildering P, Willems PJ, Verheij JB, Lindpaintner K, Vickery B, Foernzler D, van Hul W (2002) Identification of a 52\u00a0kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet 39:91\u201397","journal-title":"J Med Genet"},{"key":"1806_CR8","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/jc.2009-2283","volume":"95","author":"FS Mirza","year":"2010","unstructured":"Mirza FS, Padhi ID, Raisz LG, Lorenzo JA (2010) Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. J Clin Endocrinol Metab 95:1991\u20131997","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1806_CR9","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","volume":"23","author":"X Li","year":"2008","unstructured":"Li X, Ominsky MS, Niu Q-T, Sun N, Daugherty B, D'Agostin D, Kurahara C, Gao Y, Cao J, Gong J, Asuncion F, Barrero M, Warmington K, Dwyer D, Stolina M, Morony S, Sarosi I, Kostenuik PJ, Lacey DL, Simonet WS, Ke HZ, Paszty C (2008) Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 23(6):860\u2013869","journal-title":"J Bone Miner Res"},{"key":"1806_CR10","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","volume":"22","author":"DG Winkler","year":"2003","unstructured":"Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D, Jonas M, Kovacevich BR, Staehling-Hampton K, Appleby M, Brunkow ME, Latham JA (2003) Osteocyte control of bone formation via sclerostin, a novel of BMP antagonist. EMBO J 22:6267\u20136276","journal-title":"EMBO J"},{"key":"1806_CR11","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","volume":"146","author":"T Bellido","year":"2005","unstructured":"Bellido T, Ali AA, Gubrij I, Plotkin LI, Iu Q, O'brien CA, Manolagas SC, Jilka RL (2005) Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology 146:4577\u20134583","journal-title":"Endocrinology"},{"issue":"4","key":"1806_CR12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","volume":"24","author":"X Li","year":"2009","unstructured":"Li X, Omnisky MS, Warmington KS, Morony S, Gong J, Cao J, Gao Y, Shlhoub V, Tipton B, Haldankar R, Chen Q, Winters A, Boone T, Geng Z, Niu QT, Ke HZ, Kostenuik PJ, Simonet WS, Lacey DL, Paszty C (2009) Sclerostin antibody treatment increases bone formation, bone mass and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res 24(4):578\u2013588","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1806_CR13","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jbmr.14","volume":"25","author":"MS Ominsky","year":"2010","unstructured":"Ominsky MS, Vlasseros F, Jolette J, Smith SY, Stouch B, Doellgast G, Gong J, Gao Y, Cao J, Graham K, Tipton B, Cai J, Deshpande R, Zhou L, Hale MD, Lightwood DJ, Henry AJ, Popplewell AG, Moore AR, Robinson MK, Lacey DL, Simonet WS, Paszty C (2010) Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength. J Bone Miner Res 25(5):948\u2013959","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1806_CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jbmr.173","volume":"26","author":"D Padhi","year":"2011","unstructured":"Padhi D, Jang G, Stouch B, Fang L, Posvar E (2011) Single-dose, placebo-controlled, randomized study of AMG785, a sclerostin monoclonal antibody. J Bone Miner Res 26(1):19\u201326","journal-title":"J Bone Miner Res"},{"key":"1806_CR15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1530\/EJE-10-0699","volume":"163","author":"AH Lierop van","year":"2010","unstructured":"van Lierop AH, Witteveen JE, Hamdy NAT, Papapoulos SE (2010) Patients with primary hyperparathyroidism have lower circulating levels than euparathyroid controls. Eur J Endocrinol 163:833\u2013837","journal-title":"Eur J Endocrinol"},{"key":"1806_CR16","first-page":"462","volume":"22","author":"M-SM Ardawi","year":"2010","unstructured":"Ardawi M-SM, Qari MH, Rouzi AA, Maimani AA, Radaddi RM (2010) Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women. Osteoporos Int 22:462\u2013475","journal-title":"Osteoporos Int"},{"issue":"2","key":"1806_CR17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S8756-3282(99)00150-7","volume":"25","author":"P Christiansen","year":"1999","unstructured":"Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, Heickendroff L, Mosekilde LE (1999) Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy. Bone 25(2):237\u2013244","journal-title":"Bone"},{"key":"1806_CR18","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bone.2010.07.017","volume":"47","author":"M-SM Ardawi","year":"2010","unstructured":"Ardawi M-SM, Maimani AA, Bahksh TA, Rouzi AA, Qari MH, Radaddi RM (2010) Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a crosssectional study. Bone 47:804\u2013814","journal-title":"Bone"},{"issue":"5","key":"1806_CR19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S8756-3282(99)00207-0","volume":"25","author":"P Christianser","year":"1999","unstructured":"Christianser P, Steiniche T, Brixen K, Hessov I, Melsen F, Heickendroff L, Mosekilde LE (1999) Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients: a three-year follow-up study. Bone 25(5):589\u2013595","journal-title":"Bone"},{"key":"1806_CR20","volume-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series","author":"World Health Organization","year":"1994","unstructured":"World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series. WHO, Geneva, No. 843"},{"key":"1806_CR21","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1210\/jc.2010-0067","volume":"95","author":"A Gaudio","year":"2010","unstructured":"Gaudio A, Pennisi P, Bratengeir C, Torrisi V, Linder B, Mangiafico RA, Pulvirenti I, Hawa G, Tringali G, Fiorce CE (2010) Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab 95:2248\u20132253","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1806_CR22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jbmr.128","volume":"26","author":"UIL Modder","year":"2011","unstructured":"Modder UIL, Clowes JA, Hoey K, Peterson JM, McCready L, Oursler MJ, Riggs BL, Khosla S (2011) Regulation of circulating sclerostin levels by sex steroids in women and men. J Bone Miner Res 26(1):27\u201334","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1806_CR23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","volume":"26","author":"UI Modder","year":"2011","unstructured":"Modder UI, Hoey KA, Amin S, McCready LK, Chenbach SJ A, Riggs BL, Melton LJ III, Khosla S (2011) Relation of age, gender and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res 26(2):373\u2013379","journal-title":"J Bone Miner Res"},{"key":"1806_CR24","doi-asserted-by":"crossref","first-page":"E1159","DOI":"10.1210\/jc.2011-0254","volume":"96","author":"M McNulty","year":"2011","unstructured":"McNulty M, Singh RJ, Li X, Bergstralh EJ, Kumar R (2011) Determination of serum and plasma sclerostin concentrations by enzyme-linked immunoassays. J Clin Endocrinol Metab 96:E1159\u2013E1162","journal-title":"J Clin Endocrinol Metab"},{"key":"1806_CR25","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1210\/jc.81.10.3487","volume":"81","author":"CY Guo","year":"1996","unstructured":"Guo CY, Thomas WE, AlDehaimi AW, Assiri AM, Eastell R (1996) Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 81:3487\u20133491","journal-title":"J Clin Endocrinol Metab"},{"key":"1806_CR26","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bone.2004.05.022","volume":"35","author":"W Osterode","year":"2004","unstructured":"Osterode W, Winker R, Bieglmayer C, Vierhapper H (2004) Effects of parathyroidectomy on lead mobilization from bone in patients with primary hyperparathyroidism. Bone 35:942\u2013947","journal-title":"Bone"},{"key":"1806_CR27","doi-asserted-by":"crossref","first-page":"50259","DOI":"10.1074\/jbc.M307444200","volume":"278","author":"T Bellido","year":"2003","unstructured":"Bellido T, Ali AA, Plotkin LI, Fu Q, Gubrij I, Roberson PK, Weinstein RS, O'Brien CA, Manolagas SC, Jilka RL (2003) Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem 278:50259\u201350272","journal-title":"J Biol Chem"},{"key":"1806_CR28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","volume":"37","author":"H Keller","year":"2005","unstructured":"Keller H, Kneissel M (2005) SOST is a target gene for PTH in bone. Bone 37:148\u2013158","journal-title":"Bone"},{"key":"1806_CR29","first-page":"199","volume-title":"The parathyroids. Basic and clinical concepts","author":"JE Aubin","year":"2001","unstructured":"Aubin JE, Heersche JNM (2001) Cellular actions of parathyroid hormone on osteoblast and osteoclast differentiation. In: Bilezikian JP, Marcus R, Levine MA (eds) The parathyroids. Basic and clinical concepts. Academic, San Diego, pp 199\u2013211"},{"key":"1806_CR30","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1073\/pnas.84.7.2024","volume":"84","author":"J Pfeilschifter","year":"1987","unstructured":"Pfeilschifter J, Munday GR (1987) Modulation of type \u03b2 transforming growth factor activity in bone cultures by osteoporotic hormones. Proc Natl Acad Sci USA 84:2024\u20132028","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"1806_CR31","first-page":"5056","volume":"95","author":"MT Drake","year":"2010","unstructured":"Drake MT, Srinivasan B, Modder UI, Peterson JM, McCready LK, Riggs BL, Dwyer D, Stolina M, Kostenuik P, Khosla S (2010) Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. Bone Miner Res 95(11):5056\u20135062","journal-title":"Bone Miner Res"},{"key":"1806_CR32","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.cellsig.2009.02.012","volume":"21","author":"NS Datta","year":"2009","unstructured":"Datta NS, Abou-Samra AB (2009) PTH and PTHrP signaling in osteoblasts. Cell Signal 21:1245\u20131254","journal-title":"Cell Signal"},{"key":"1806_CR33","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","volume":"40","author":"RL Jilka","year":"2007","unstructured":"Jilka RL (2007) Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40:1434\u20131446","journal-title":"Bone"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-011-1806-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-011-1806-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-011-1806-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:08:41Z","timestamp":1558624121000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-011-1806-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,28]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["1806"],"URL":"https:\/\/doi.org\/10.1007\/s00198-011-1806-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,28]]}}}